Delivery Order N6264520D5002-N6264521F0297
- Not listed
- This is a firm fixed-price delivery order worth $1,116,048.58 awarded by the Defense Health Agency (DHA) to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The contract is for the supply of radiopharmaceutical supplies, which are critical for nuclear medicine, oncology, and diagnostic imaging services across federal healthcare facilities. Cardinal Health 414, LLC is an established provider of specialized medical isotopes and radiopharmaceutical therapies to federal agencies,...
- The Defense Health Agency awarded a firm fixed price delivery order contract worth up to $250,000.00 to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc., for the provision of radiopharmaceuticals. The contract, which has no set-aside designation, will run through September 30, 2022. Cardinal Health 414 has previously held multiple indefinite delivery contracts to supply radiopharmaceuticals, radioactive isotopes, and other nuclear medicine products and services to the Department...
- This is a federal contract award to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc., a global healthcare services company. The contract, valued at $94,333.31, is for the provision of radiopharmaceuticals to the Department of Veterans Affairs (VA). The contract is a Delivery Order under a larger Indefinite Delivery Vehicle (IDV) contract, with a period of performance ending on October 31, 2019. Cardinal Health 414 is a for-profit limited liability company that specializes in...
- Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc., was awarded a delivery order contract by the Defense Health Agency for radiopharmaceuticals with a ceiling value of $563,789.91 under a firm fixed-price arrangement. The award, issued on October 7, 2021, with an ultimate completion date of September 30, 2026, carries no set-aside designation and reflects performance at the awardee's Jacksonville, Florida facility. Cardinal Health 414 specializes in the manufacturing, testing, and...
- Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. specializing in radiopharmaceuticals and medical isotopes, was awarded a firm fixed-price purchase order valued at $249,466.62 by the Defense Health Agency on September 1, 2023. The contract, with an ultimate completion date of September 30, 2026, procures radiopharmaceutical products for use across the Defense Health Agency's military treatment facilities. Cardinal Health 414 will perform work from its primary facility in Dublin,...
- This firm fixed price delivery order contract was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The contract is for the provision of radiopharmaceutical supplies and related products and services to the VA. The potential value of the contract is $864,054.49. The contract has no set-aside designation and was awarded on October 1, 2018 with a completion date of June 30, 2020. Cardinal Health...
- This is a delivery order contract awarded by the Department of Veterans Affairs (VA) to Cardinal Health 414, LLC for the supply of radiopharmaceuticals. The contract has a ceiling value of $444,465.68 and is a firm fixed price contract with an ultimate completion date of October 14, 2019. The contract is not set aside for any specific business type. Cardinal Health 414, LLC is a subsidiary of Cardinal Health, Inc. and specializes in providing radiopharmaceuticals, radioactive isotopes, and...
- This is a firm fixed-price delivery order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The $182,653.59 contract is for the purchase of radiopharmaceuticals, with no set-aside designation. Cardinal Health 414 has provided similar pharmaceutical products and services, including radioactive isotopes, diagnostic imaging agents, and specialty cancer treatments, to the VA, Department of Defense,...
- This is a delivery order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Cardinal Health 414, LLC, a subsidiary of the global healthcare firm Cardinal Health, Inc. The $431,030.86 firm fixed price contract is for the delivery of radiopharmaceuticals to support nuclear medicine, oncology, and other patient care programs at VA facilities. Cardinal Health 414 holds several indefinite delivery vehicle (IDV) contracts with the VA to provide radiopharmaceuticals...
- This is a delivery order awarded by the Department of Veterans Affairs (VA) to Cardinal Health 414, LLC for the provision of radiopharmaceuticals. The award, valued at $240,832.62, covers the third option year of a contract that runs from October 1, 2016 through September 30, 2018. Cardinal Health 414 is a subsidiary of Cardinal Health, Inc., a global healthcare services company that specializes in supplying radiopharmaceuticals and other specialized pharmaceutical products to federal healthcare...
- N6264520D5002Indefinite Delivery Contract
- N6264520D5002-N6264521F0297Delivery Order
This is a firm fixed-price delivery order awarded by the Defense Health Agency (DHA) to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc., for the supply of radiopharmaceutical products. The $738,865.37 contract covers the period from October 1, 2021, to September 30, 2022, and supports the DHA's nuclear medicine and diagnostic imaging requirements. Cardinal Health 414, LLC is a prominent supplier of specialized medical isotopes and radiopharmaceutical therapies to federal healthcare agencies, including the Department of Veterans Affairs (VA) and National Institutes of Health (NIH). This delivery order is part of a larger Indefinite Delivery Vehicle (IDV) contract that Cardinal Health 414, LLC holds with the VA, allowing for both scheduled and emergency deliveries of critical medical isotopes to VA medical centers and other federal facilities. The contract has no set-aside designation, reflecting Cardinal Health 414, LLC's status as a large, established healthcare product supplier capable of meeting complex federal requirements.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
NMCP RADIOPHARMACEUTICALS | N6264519R0087 | Department of the Navy Bureau of Medicine and Surgery | Solicitation 1/1 | 9/30/19, 12:46 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00004 | Other Administrative Action | $431.0k | 4/20/22 | |
| P00003 | Other Administrative Action | $184.7k | 3/10/22 | |
| P00002 | Other Administrative Action | $123.1k | 1/25/22 | |
| P00001 | Other Administrative Action | $0 | 11/5/21 | |
| Not listed | Not listed | $0 | 9/29/21 |